Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Residue Testing Market Research Report by Residue Type (Allergens, Heavy Metals, Pesticides, and Toxins), by Detection Techniques (HPLC, Immunoassay-based, and LC-MS/MS), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
... Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available. 1. The ... Read More
-
Interferons Global Market Report 2021: COVID 19 Implications And Growth to 2030
... the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for interferons which play a critical role in ... Read More
-
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis), by Type (Full line Wholesalers and Specialty Distributors), by Distribution Type, by Distribution Channel - Global
... 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market 2021 by Company, Regions, Type and Application, Forecast to 2026
... size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, ... Read More
-
Multiple Sclerosis Therapeutics
... projected to reach a revised size of US$22.3 Billion by 2027, growing at a CAGR of 1.3% over the analysis period 2020-2027. Beta Interferon, one of the segments analyzed in the report, is projected to ... Read More
-
Beta Interferon
... a revised size of US$3.7 Billion by 2027, growing at a CAGR of 2.6% over the period 2020-2027. The U.S. Market is Estimated at $846.4 Million, While China is Forecast to Grow at 4.1% CAGR ... Read More
-
Digital Health in Neurology - Thematic Research
... For many patients living with neurological conditions, treatment can be episodic and infrequent, leaving them vulnerable. Digital health technologies provide opportunities to improve disease treatment and management for these patients, as well as being individualized ... Read More
-
Multiple Sclerosis Disease - Global Clinical Trials Review, H1, 2021
... This report provides top line data relating to the clinical trials on Multiple Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmacies, Retail Phar
... and Geography The Multiple Sclerosis Therapeutics market was valued at US$ 24,026.90 million in 2019 and it is projected to reach US$ 39,223.59 million by 2027; it is expected to grow at a CAGR of ... Read More
-
Autoimmune Disease Drug Market Research Report by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases, and Rheumatic Diseases), by Drug Class (Anti-inflammatory, Antihyperglycemic, Immunosuppressants, Interferons, and NSAIDs), by Distr
... to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when ... Read More
-
Electronic Drug Delivery System Market Research Report by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps), by Indication (Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple
... States Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better ... Read More
-
Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - Global Forecast to 2025 - Cumulative Impact of COVID-19
... sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available. 1. The Global Multiple Sclerosis Market is ... Read More
-
Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - United States Forecast to 2025 - Cumulative Impact of COVID-19
... market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available. The United States Multiple Sclerosis Market ... Read More
-
Neuroprotection Market Research Report by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, and Neurotrophic Factors), by Treatment (Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury,
... Application - United States Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization ... Read More
-
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis), by Type (Full line Wholesalers and Specialty Distributors), by Distribution Type, by Distribution Channel - United
... to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when ... Read More
-
Neuroprotection Market Research Report by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, and Neurotrophic Factors), by Treatment (Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury,
... Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Neuroprotection Market is expected to grow from USD 11,234.69 Million/EUR 9,850.78 Million in 2020 to USD 17,151.24 Million/EUR 15,038.53 by the end ... Read More
-
Electronic Drug Delivery System Market Research Report by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps), by Indication (Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple
... Forecast to 2025 - Cumulative Impact of COVID-19 The Global Electronic Drug Delivery System Market is expected to grow from USD 8,392.63 Million/EUR 7,358.82 Million in 2020 to USD 12,818.39 Million/EUR 11,239.40 by the end ... Read More
-
Autoimmune Disease Drug Market Research Report by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases, and Rheumatic Diseases), by Drug Class (Anti-inflammatory, Antihyperglycemic, Immunosuppressants, Interferons, and NSAIDs), by Distr
... 2025 - Cumulative Impact of COVID-19 The Global Autoimmune Disease Drug Market is expected to grow from USD 88,236.20 Million/EUR 77,367.17 Million in 2020 to USD 120,866.46 Million/EUR 105,978.01 by the end of 2025 at ... Read More
-
Global Autoinjectors Market By Type (Disposable Autoinjectors and Reusable Autoinjectors), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications), By End Use (Hospitals & Clinics and Home care settings), By Region, I
... and Forecast, 2020 - 2026 The Global Autoinjectors Market size is expected to reach $5.3 billion by 2026, rising at a market growth of 17.6% CAGR during the forecast period. An autoinjector is a medical ... Read More
-
North America Autoinjectors Market By Type (Disposable autoinjectors and Reusable autoinjectors), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications), By End Use (Hospitals & Clinics and Home care settings), By Co
... Analysis and Forecast, 2020 - 2026 The North America Autoinjectors Market would witness market growth of 16.9% CAGR during the forecast period (2020-2026). As per the US National Health Council, approximately 75% of the healthcare ... Read More
-
Europe Autoinjectors Market By Type (Disposable autoinjectors and Reusable autoinjectors), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications), By End Use (Hospitals & Clinics and Home care settings), By Country,
... and Forecast, 2020 - 2026 The Europe Autoinjectors Market would witness market growth of 17.1% CAGR during the forecast period (2020-2026). Auto-injectors have numerous advantages like they lessen phobia and anxiety related to needles, decrease ... Read More
-
Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular Diseases, Diabetes), Type (Disposable, Reusable), Route of administration (Subcutaneous, Intramuscular), End User (Hospital) - Global Forecast to 2025
... to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the ... Read More
-
Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
... immune-mediated condition that can cause demyelination, axonal transection and neurodegeneration of the nerve cells in the spinal cord and brain. Some of the commonly used therapies include the administration of injectable, oral and infused medicines, ... Read More
-
Multiple Sclerosis Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)
... of multiple sclerosis (MS) and the growing focus of companies on pipeline products for MS. Big pharmaceutical companies have been investing heavily in the drug development process and are planning to target as many indications ... Read More
-
Global Multiple Sclerosis Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
... of 2020 to 2025, with a CAGR of 1.9% in the forecast period of 2020 to 2025 and will expected to reach USD 18910 million by 2025, from USD 17530 million in 2019. The Multiple ... Read More
